ReviewPulmonary circulation2024

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.

Oksana A Shlobin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.